Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer in general practice research priorities in Australia.
Milley K, Druce P, McNamara M, Bergin RJ, Chan RJ, Cust AE, Davis N, Fishman G, Jefford M, Rankin N, Yates P, Emery J. Milley K, et al. Among authors: mcnamara m. Aust J Gen Pract. 2024 Apr;53(4):227-234. doi: 10.31128/AJGP-02-23-6699. Aust J Gen Pract. 2024. PMID: 38575544 Free article.
A systematic review of smartphone applications for cancer survivors.
Changrani K, Chima S, Sharma A, Han GG, Sharma A, McNamara M, Jefford M, Emery J, Druce P. Changrani K, et al. Among authors: mcnamara m. J Cancer Surviv. 2023 Sep 12. doi: 10.1007/s11764-023-01435-9. Online ahead of print. J Cancer Surviv. 2023. PMID: 37700151 Review.
Sodium Bicarbonate for Metabolic Acidosis in the ICU: Results of a Pilot Randomized Double-Blind Clinical Trial.
Serpa Neto A, Fujii T, McNamara M, Moore J, Young PJ, Peake S, Bailey M, Hodgson C, Higgins AM, See EJ, Secombe P, Campbell L, Young M, Maeda M, Pilcher D, Nichol A, Deane A, Licari E, White K, French C, Shehabi Y, Cross A, Maiden M, Kadam U, El Khawas K, Cooper J, Bellomo R, Udy A. Serpa Neto A, et al. Among authors: mcnamara m. Crit Care Med. 2023 Nov 1;51(11):e221-e233. doi: 10.1097/CCM.0000000000005955. Epub 2023 Jun 9. Crit Care Med. 2023. PMID: 37294139 Clinical Trial.
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Oh DY, He AR, Bouattour M, Okusaka T, Qin S, Chen LT, Kitano M, Lee CK, Kim JW, Chen MH, Suksombooncharoen T, Ikeda M, Lee MA, Chen JS, Potemski P, Burris HA 3rd, Ostwal V, Tanasanvimon S, Morizane C, Zaucha RE, McNamara MG, Avallone A, Cundom JE, Breder V, Tan B, Shimizu S, Tougeron D, Evesque L, Petrova M, Zhen DB, Gillmore R, Gupta VG, Dayyani F, Park JO, Buchschacher GL Jr, Rey F, Kim H, Wang J, Morgan C, Rokutanda N, Żotkiewicz M, Vogel A, Valle JW. Oh DY, et al. Among authors: mcnamara mg. Lancet Gastroenterol Hepatol. 2024 May 29:S2468-1253(24)00095-5. doi: 10.1016/S2468-1253(24)00095-5. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38823398
860 results